Vi Labs (@Vi_Labs_AI) header
Vi Labs (@Vi_Labs_AI) profile picture

The AI execution layer for healthcare, life sciences, and wellness. Turning enterprise data into next-best actions.

NYC, NY
Joined January 2026
Photo by Vi Labs (@Vi_Labs_AI)Photo by Vi Labs (@Vi_Labs_AI)Photo by Vi Labs (@Vi_Labs_AI)Photo by Vi Labs (@Vi_Labs_AI)Photo by Vi Labs (@Vi_Labs_AI)Photo by Vi Labs (@Vi_Labs_AI)Photo by Vi Labs (@Vi_Labs_AI)Photo by Vi Labs (@Vi_Labs_AI)Photo by Vi Labs (@Vi_Labs_AI)
AI is reshaping what’s possible in healthcare. @Vi_Labs_AI CEO Omri Yoffe joins The Signal to discuss turning complex data into action and building a future of more personalized, accessible care.
2
1
8
3,478
The pilot shouldn’t be where you figure out the business case. Vi works out pricing, ROI, integration, and the path to scale upfront, so the pilot is more of a validation vs experiment. That’s a big reason 90%+ of Vi pilots move into scaled deployments.
2
2
9
1,712
NEW: Company Deep Dive — Vi We sat down with Vi CEO & Founder Omri Yoffe and Spencer Honeyman, President of Global Growth, to unpack its AI execution layer: turning data into action across healthcare workflows. We cover its data moat, agents, and outcome-based pricing. Link 👇
3
5
2
19
1,984
Most AI demos built for healthcare don't survive in real clinical or operational environments. The data is messy, the workflows are fragmented, margin for error is near zero. That's why I'm stoked to host a 1.5-day Healthcare x AI Hackathon with @HealthcareAIGuy in NYC: a small group of engineers, founders, PMs, and builders who are serious about applying AI agents and tools to healthcare problems in production. Stack: @Baseten, @Lovable, @ElevenLabs Cash prizes. And a few surprises. 📍 NYC | June 26–27 Space is limited and application-based. Apply by June 17th at 11:59 pm ET → link below
7
7
2
29
6,290
The team at @Vi_Labs_AI has scaled from zero to nine-figure ARR profitably in a matter of a few years. Their team is providing an AI execution layer for healthcare and life sciences that doesn’t replace the team or existing technology.
2
1
2
122
$145M raised: Vi has closed a $145 million transaction valuing the company at $1.64 billion, with shareholders General Atlantic, Revelstoke Capital Partners, 1902 Capital (the Pritzker Organization), Square Peg Capital, Savano Capital Partners, and Island Green Capital. The deal is a mix of primary and secondary capital, providing growth funding for the company and liquidity for existing investors. Vi has been quietly profitable for over five years and growing more than 120% year-over-year. Vi sells an enterprise AI platform for healthcare, life sciences, and wellness companies, and just launched a suite of vertically specialized AI agents that act as an execution layer across the industry. The agents handle patient care navigation, next-best-action prompts for physicians, clinical trial acceleration, drug commercialization, and operational optimization. Customers include over 100 healthcare systems, biopharma firms, and wellness enterprises. Vi has supported more than 50 drug launches, touches 190 million lives, and claims more than $2 billion in measurable customer value. The differentiator is the underlying dataset. Vi calls it the Data Web, one of the largest health-related datasets globally, spanning clinical, behavioral, and operational signals with coverage of 96% of US households across more than 70,000 data sets. That data is what lets the new agents make real-time decisions instead of sitting on top of static records. CEO Omri Yoffe has been building Vi for more than a decade out of New York and Tel Aviv, with additional engineering teams in Boston, Austin, and Nashville. The capital funds talent retention and hiring, platform R&D, and the launch and scale of the new agents suite. It lands as CMS and the FDA accelerate guidance on AI in clinical workflows, putting Vi up against Tempus AI, Komodo Health, Innovaccer, Hippocratic AI, and Abridge for the layer that sits between data and decision.
1
2
4
178